Minocycline up-regulates the expression of brain-derived neurotrophic factor and nerve growth factor in experimental autoimmune encephalomyelitis

European Journal of Pharmacology

Volumn 686, Issue 1-3, 2012, Pages 124-129

  Chen, Xiaohong ^a   Ma, Lili ^a   Jiang, Ying ^a   Chen, Shaoqiong ^a   Zhu, Cansheng ^a   Liu, Mei ^a   Ma, Xiaomeng ^a   Zhu, Dongliang ^a   Liu, Yingying ^a   Peng, Fuhua ^a   Wang, Qing ^a   Pi, Rongbiao ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Brain derived neurotrophic factor; Experimental autoimmune encephalomyelitis; Minocycline; Multiple sclerosis; Nerve growth factor

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; MINOCYCLINE; NERVE GROWTH FACTOR;

ALLERGIC ENCEPHALOMYELITIS; ANATOMICAL VARIATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; ENZYME REGULATION; FEMALE; IN VITRO STUDY; IN VIVO STUDY; LUMBAR SPINAL CORD; MOUSE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SPLEEN CELL; TREATMENT RESPONSE;

ANIMALS; ANTI-BACTERIAL AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CEREBRAL CORTEX; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; MICE; MICE, INBRED C57BL; MINOCYCLINE; NERVE GROWTH FACTOR; SPINAL CORD; SPLEEN; UP-REGULATION;

EID: 84861583664     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2012.04.043     Document Type: Article

References (39)

1. L. Aloe, S.D. Skaper, A. Leon, and R. Levi-Montalcini Nerve growth factor and autoimmune disease Autoimmunity 19 1994 141 150
2. L.R. Arredondo, C. Deng, R.B. Ratts, A.E. Lovett-Racke, D.M. Holtzman, and M.K. Racke Role of nerve growth factor in experimental autoimmune encephalomyelitis Eur. J. Immunol. 31 2001 625 633
3. D. Azoulay, N. Urshansky, and A. Karni Low and dysregulated BDNF secretion from immune cells of MS patients is related to reduced neuroprotection J. Neuroimmunol. 195 2008 186 193
4. D. Azoulay, K. Mausner-Fainberg, N. Urshansky, F. Fahoum, and A. Karni Interferon-β therapy up-regulates BDNF secretion from PBMCs of MS patients through a CD40-dependent mechanism J. Neuroimmunol. 211 2009 114 119
5. C. Bjartmar, J.R. Wujek, and B.D. Trapp Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease J. Neurol. Sci. 206 2003 165 171
6. T. Boutros, E. Croze, and V.W. Yong Interferon-beta is a potent promoter of nerve growth factor production by astrocytes J. Neurochem. 69 1997 939 946
7. V. Brundula, N.B. Rewcastle, L.M. Metz, C.C. Bernard, and V.W. Yong Targeting leukocyte MMPs and transmigration: minocycline as a potential therapy for multiple sclerosis Brain 125 2002 1297 1308
8. M. Caggiula, A.P. Batocchi, G. Frisullo, F. Angelucci, A.K. Patanella, C. Sancricca, V. Nociti, P.A. Tonali, and M. Mirabella Neurotrophic factors and clinical recovery in relapsing-remitting multiple sclerosis Scand. J. Immunol. 62 2005 176 182
9. M. Chen, R.M. Valenzuela, and S. Dhib-Jalbut Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor J. Neurol. Sci. 215 2003 37 44
10. X.H. Chen, X.Q. Hu, Y. Zou, R.P. Pi, M. Liu, T.Q. Wang, X.P. Zheng, M. Liu, M.D. Lin, P.Q. Liu, and L. Tao Combined treatment with minocycline and prednisone attenuates experimental autoimmune encephalomyelitis in C57 BL/6 mice J. Neuroimmunol. 210 2009 22 29
11. X.H. Chen, X.M. Ma, Y. Jiang, R.B. Pi, Y.Y. Liu, and L.L. Ma The prospects of minocycline in multiple sclerosis J. Neuroimmunol. 235 2011 1 8
12. G. D'Intino, M. Paradisi, M. Fernandez, A. Giuliani, L. Aloe, L. Giardino, and L. Calza Cognitive deficit associated with cholinergic and nerve growth factor down-regulation in experimental allergic encephalomyelitis in rats Proc. Natl. Acad. Sci. U. S. A. 102 2005 3070 3075
13. L. De Santi, P. Annunziata, E. Sessa, and P. Bramanti Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis J. Neurol. Sci. 287 2009 17 26
14. L. De Santi, G. Polimeni, S. Cuzzocrea, E. Esposito, E. Sessa, P. Annunziata, and P. Bramanti Neuroinflammation and neuroprotection: an update on (future) neurotrophin-related strategies in multiple sclerosis treatment Curr. Med. Chem. 18 2011 1775 1784
15. M. Ebadi, R.M. Bashir, M.L. Heidrick, F.M. Hamada, H. El Refaey, A. Hamed, G. Helal, M.D. Baxi, D.R. Cerutis, and N.K. Lassi Neurotrophins and their receptors in nerve injury and repair Neurochem. Int. 30 1997 347 374
16. L.F. Eng, F.E. D'Amelio, and M.E. Smith Dissociation of GFAP intermediate filaments in EAE: observations in the lumbar spinal cord Glia 2 1989 308 317
17. S. Guo, W.J. Kim, J. Lok, S.R. Lee, E. Besancon, B.H. Luo, M.F. Stins, X. Wang, S. Dedhar, and E.H. Lo Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons Proc. Natl. Acad. Sci. U. S. A. 105 2008 7582 7587
18. H. Hammarberg, O. Lidman, C. Lundberg, S.Y. Eltayeb, A.W. Gielen, S. Muhallab, A. Svenningsson, H. Lindå, P.H. van Der Meide, S. Cullheim, T. Olsson, and F. Piehl Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells J. Neurosci. 20 2000 5283 5291
19. Y. Ji, Y. Lu, F. Yang, W. Shen, T.T. Tang, L. Feng, S. Duan, and B. Lu Acute and gradual increases in BDNF concentration elicit distinct signaling and functions in neurons Nat. Neurosci. 13 2010 302 309
20. B.M. Keegan, and J.H. Noseworthy Multiple sclerosis Annu. Rev. Med. 53 2002 285 302
21. M. Kerschensteiner, E. Gallmeier, L. Behrens, W.E.F. Klinkert, R. Kolbeck, and E. Hoppe Activated human T cells, B cells and monocytes produce brain-derived neurotrophic factor (BDNF) in vitro and in brain lesions: a neuroprotective role of inflammation J. Exp. Med. 189 1999 865 870
22. S. Kuerten, D.A. Kostova-Bales, L.P. Frenzel, J.T. Tigno, M. Tary-Lehmann, D.N. Angelov, and P.V. Lehmann MP4- and MOG:35-55-induced EAE in C57BL/6 mice differentially targets brain, spinal cord and cerebellum J. Neuroimmunol. 189 2007 31 40
23. L.B. Laudiero, L. Aloe, R. Levi-Montalcini, C. Buttinelli, D. Schilter, S. Gillessen, and U. Otten Multiple sclerosis patients express increased levels of beta-nerve growth factor in cerebrospinal fluid Neurosci. Lett. 147 1992 9 12
24. V. Lessmann, K. Gottmann, and M. Malcangio Neurotrophin secretion: current facts and future prospects Prog. Neurobiol. 69 2003 341 374
25. T.K. Makar, D. Trisler, K.T. Sura, S. Sultana, N. Patel, and C.T. Bever Brain derived neurotrophic factor treatment reduces inflammation and apoptosis in experimental allergic encephalomyelitis J. Neurol. Sci. 270 2008 70 76
26. H. Nomoto, M. Takaiwa, A. Mouri, and S. Furukawa Pro-region of neurotrophins determines the processing efficiency Biochem. Biophys. Res. Commun. 356 2007 919 924
27. J.H. Noseworthy, C. Lucchinetti, M. Rodriguez, and B.G. Weinshenker Multiple sclerosis N. Engl. J. Med. 343 2000 938 952
28. E.J. O'Neill, M.J. Day, and D.C. Wraith IL-10 is essential for disease protection following intranasal peptide administration in the C57BL/6 model of EAE J. Neuroimmunol. 178 2006 1 8
29. W. Pan, W.A. Banks, M.B. Fasold, J. Bluth, and A.J. Kastin Transport of brain-derived neurotrophic factor across the blood-brain barrier Neuropharmacology 37 1998 1553 1561
30. W. Pan, W.A. Banks, and A.J. Kastin Permeability of the blood-brain barrier to neurotrophins Brain Res. 788 1998 87 94
31. N. Popovic, A. Schubart, B.D. Goetz, S.C. Zhang, C. Linington, and I.D. Duncan Inhibition of autoimmune encephalomyelitis by a tetracycline Ann. Neurol. 51 2002 215 223
32. T. Sakane, and W.M. Pardridge Carboxyl-directed pegylation of brain-derived neurotrophic factor markedly reduces systemic clearance with minimal loss of biologic activity Pharm. Res. 14 1997 1085 1091
33. P. Sarchielli, L. Greco, A. Stipa, A. Floridi, and V. Gallai Brain-derived neurotrophic factor in patients with multiple sclerosis J. Neuroimmunol. 132 2002 180 188
34. H. Thoenen Neurotrophins and neuronal plasticity Science 270 1997 593 598
35. B.D. Trapp, J. Peterson, R.M. Ransohoff, R.A. Rudick, S. Mork, and L. Bo Axonal transaction in the lesions of multiple sclerosis N. Engl. J. Med. 388 2004 278 285
36. V. Triaca, P. Tirassa, and L. Aloe Presence of nerve growth factor and TrkA expression in the SVZ of EAE rats: evidence for a possible functional significance Exp. Neurol. 191 2005 53 64
37. E.G. Waterhouse, and B. Xu New insights into the role of brain-derived neurotrophic factor in synaptic plasticity Mol. Cell. Neurosci. 42 2009 81 89
38. V.W. Yong, J. Wells, F. Giuliani, S. Casha, C. Power, and L.M. Metz The promise of minocycline in neurology Lancet Neurol. 3 2004 744 751
39. T. Ziemssen, T. Kümpfel, H. Schneider, W.E.F. Klinkert, O. Neuhaus, and R. Hohlfeld Secretion of brain-derived neurotrophic factor by glatiramer acetatereactive T-helper cell lines: Implications for multiple sclerosis therapy J. Neurol. Sci. 233 2005 109 112